Answers are grounded in this paper and cite their sources.
Background and Objective Electronic Nose (eNose) breathprints are promising non‐invasive lung cancer diagnostic tools, but cross‐site validation and adaptation remain barriers to clinical applications. It remains unknown whether a natural language processing‐pretrained large language model (LLM) can enable few‐shot, site‐specific classification of lung cancer using eNose breathprints. Methods We collected eNose breathprints of lung cancer and non‐lung cancer patients from two medical centres in Taiwan. A GPT‐2–backbone LLM with parameter‐efficient adaptation was compared with convolutional neural networks (CNN) trained from scratch or pretrained on CIFAR‐100. Few‐shot protocols (2–6 shots per class) and full‐data training were evaluated. Results We collected 432 eNose breathprints from two sites (S1 and S2). With 6 labelled samples per class (6 shots), LLM achieved an area under the curve (AUC) of 0.79 (95% CI: 0.71–0.87), sensitivity of 0.74 (0.63–0.83), and specificity of 0.77 (0.67–0.87) on S1. On S2, it achieved an AUC of 0.76 (0.69–0.82), sensitivity of 0.77 (0.69–0.84), and specificity of 0.61 (0.51–0.70). LLM outperforms scratch CNN models (S1; AUC: 0.44, p = 0.0002) (S2; AUC: 0.63, p = 0.0198) and CNN pretrained on CIFAR‐100 images (S1; AUC: 0.57, p = 0.0100) and (S2; AUC: 0.61, p = 0.0248). LLM or a CNN model trained on the source site fails to improve performance after transferring to the target site for fine‐tuning; for the LLM, performance even deteriorates. Conclusion Our study demonstrates the potential of pretrained LLMs for few‐shot lung cancer classification in a real‐world mixed clinical cohort, reducing dependence on large training datasets.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: